Sign Up to Receive the Latest Trading Tips and News from Prosper

    February 7, 2019

    Look Out Below For Sangamo Therapeutics

    Sangamo Therapeutics (SGMO) shares slumped over -30% lower due to a failed Phase 1/2 study. The company reported its SB-318 genome editing product did not appear to show any clinical benefits. The company does have an extensive pipeline of treatments in clinical trials, as well as partnerships with major companies such as Pfizer. However, this […]

    Read Article
    February 5, 2019

    Evolus, Part II

    Evolus, Inc. (EOLS) is up again today following FDA approval of its first product, Jeuveau, on Friday. The stock was up over 25% at the time this content was recorded. Part of this rally is likely due to the fact that the stock had a large percentage of short positions. In fact, nearly a fifth […]

    Read Article